ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 219 filers reported holding ICU MED INC in Q1 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $7,946,256 | +36.1% | 66,916 | +23.0% | 0.01% | +16.7% |
Q1 2024 | $5,837,841 | -5.8% | 54,397 | -12.4% | 0.01% | 0.0% |
Q4 2023 | $6,194,606 | -16.4% | 62,108 | -0.2% | 0.01% | -33.3% |
Q3 2023 | $7,409,760 | -33.7% | 62,262 | -0.8% | 0.01% | -30.8% |
Q2 2023 | $11,180,531 | +104147.4% | 62,745 | -3.5% | 0.01% | 0.0% |
Q1 2023 | $10,725 | +4.1% | 65,015 | -0.7% | 0.01% | -7.1% |
Q4 2022 | $10,307 | -99.9% | 65,448 | +7.4% | 0.01% | 0.0% |
Q3 2022 | $9,178,000 | -5.5% | 60,941 | +3.1% | 0.01% | 0.0% |
Q2 2022 | $9,717,000 | -17.9% | 59,112 | +11.2% | 0.01% | -6.7% |
Q1 2022 | $11,834,000 | -8.5% | 53,155 | -2.5% | 0.02% | -6.2% |
Q4 2021 | $12,937,000 | +4.0% | 54,507 | +2.2% | 0.02% | -5.9% |
Q3 2021 | $12,443,000 | +10.4% | 53,315 | -2.6% | 0.02% | +13.3% |
Q2 2021 | $11,271,000 | -1.2% | 54,766 | -1.3% | 0.02% | 0.0% |
Q1 2021 | $11,403,000 | -5.2% | 55,505 | -1.0% | 0.02% | -11.8% |
Q4 2020 | $12,023,000 | +17.7% | 56,053 | +0.3% | 0.02% | +6.2% |
Q3 2020 | $10,216,000 | -3.1% | 55,899 | -2.3% | 0.02% | -11.1% |
Q2 2020 | $10,548,000 | -6.0% | 57,230 | +2.9% | 0.02% | -25.0% |
Q1 2020 | $11,221,000 | +13.6% | 55,614 | +5.4% | 0.02% | +41.2% |
Q4 2019 | $9,877,000 | +16.0% | 52,782 | -1.0% | 0.02% | +6.2% |
Q3 2019 | $8,511,000 | -31.8% | 53,330 | +7.6% | 0.02% | -30.4% |
Q2 2019 | $12,484,000 | +13.6% | 49,559 | +8.0% | 0.02% | +9.5% |
Q1 2019 | $10,985,000 | +5.5% | 45,901 | +1.3% | 0.02% | -8.7% |
Q4 2018 | $10,408,000 | +11.3% | 45,326 | +37.1% | 0.02% | +27.8% |
Q3 2018 | $9,349,000 | -3.2% | 33,065 | +0.5% | 0.02% | -5.3% |
Q2 2018 | $9,661,000 | +22.6% | 32,901 | +5.4% | 0.02% | +18.8% |
Q1 2018 | $7,877,000 | +0.8% | 31,209 | -13.7% | 0.02% | 0.0% |
Q4 2017 | $7,812,000 | +35.0% | 36,168 | +16.2% | 0.02% | +23.1% |
Q3 2017 | $5,786,000 | +9.8% | 31,131 | +1.9% | 0.01% | +8.3% |
Q2 2017 | $5,271,000 | +12.1% | 30,556 | -0.8% | 0.01% | +9.1% |
Q1 2017 | $4,703,000 | +45.0% | 30,799 | +39.9% | 0.01% | +37.5% |
Q4 2016 | $3,243,000 | +21.8% | 22,009 | +4.4% | 0.01% | +14.3% |
Q3 2016 | $2,663,000 | +18.4% | 21,073 | +5.6% | 0.01% | 0.0% |
Q2 2016 | $2,250,000 | +2.9% | 19,954 | -5.0% | 0.01% | 0.0% |
Q1 2016 | $2,187,000 | -1.0% | 21,009 | +7.3% | 0.01% | 0.0% |
Q4 2015 | $2,209,000 | +7.9% | 19,584 | +4.8% | 0.01% | 0.0% |
Q3 2015 | $2,047,000 | +20.8% | 18,692 | +5.5% | 0.01% | +40.0% |
Q2 2015 | $1,695,000 | -13.0% | 17,715 | -15.3% | 0.01% | -16.7% |
Q1 2015 | $1,948,000 | +14.8% | 20,915 | +1.0% | 0.01% | +20.0% |
Q4 2014 | $1,697,000 | +34.3% | 20,715 | +5.2% | 0.01% | +25.0% |
Q3 2014 | $1,264,000 | +1.9% | 19,690 | -3.5% | 0.00% | 0.0% |
Q2 2014 | $1,241,000 | +29.3% | 20,410 | +27.3% | 0.00% | +33.3% |
Q1 2014 | $960,000 | -9.9% | 16,030 | -4.1% | 0.00% | 0.0% |
Q4 2013 | $1,065,000 | -8.1% | 16,715 | -2.1% | 0.00% | -25.0% |
Q3 2013 | $1,159,000 | -5.7% | 17,065 | +0.0% | 0.00% | 0.0% |
Q2 2013 | $1,229,000 | – | 17,059 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sandhill Capital Partners LLC | 91,082 | $20,915,000 | 3.45% |
CROWN ADVISORS MANAGEMENT, INC. | 14,000 | $3,215,000 | 3.34% |
PURA VIDA INVESTMENTS, LLC | 65,119 | $14,953,000 | 2.98% |
Lyon Street Capital, LLC | 11,105 | $2,550,000 | 2.56% |
GW&K Investment Management, LLC | 412,350 | $94,688,000 | 1.87% |
Penn Capital Management Company, LLC | 51,722 | $14,451,000 | 1.43% |
Hotaling Investment Management, LLC | 6,351 | $1,458,000 | 1.19% |
PFM Health Sciences, LP | 175,758 | $40,359,000 | 1.07% |
DIXON HUBARD FEINOUR & BROWN INC/VA | 12,430 | $2,854,000 | 1.06% |
GAM Holding AG | 90,452 | $20,769,000 | 1.05% |